Patents for A61P 17 - Drugs for dermatological disorders (106,455)
10/1996
10/17/1996WO1996027006A3 Human vegf-specific antisense oligonucleotides
10/17/1996DE19514048A1 Trapidil zur Verwendung in der Therapie von immunmodulatorisch beeinflußbaren Krankheitsbildern Trapidil for use in the treatment of immunomodulatory influenced diseases
10/16/1996EP0737211A1 Cationic biopolymers
10/16/1996EP0737204A1 Cs-1 peptidomimetics, compositions and methods of using the same
10/16/1996EP0737200A1 Biologically active silicon compounds and their therapeutic and cosmetic applications
10/16/1996EP0737199A1 Method for preparing concentrated biologically active silicon compounds
10/16/1996EP0737195A1 New ginkgolide derivatives and a process for preparing them
10/16/1996EP0737190A1 [4-(1,2-epoxycyclohexanyl) but-3-en-1-ynyl] aromatic and heteroaromatic acids and derivatives having retinoid-like biological activity
10/16/1996EP0737176A1 Process for isomerizing linear olefins to isoolefins
10/16/1996EP0737074A1 Botulinum toxins for treating various disorders and associated pain
10/16/1996EP0737070A1 Vitamin d 3? analogues and pathway to mediate disorders
10/16/1996EP0737069A1 Deuterised active agents in transdermal application
10/16/1996EP0571546B1 Chroman and thiochromans with phenylethynyl substituents at the 7-position having retinoid-like biological activity
10/16/1996EP0540673B1 Acetylene derivatives having lipoxygenase inhibitory activity
10/16/1996CN1133616A A novel nuclear mitotic phosphoprotein:mitosin
10/16/1996CN1133287A Inhibitor for squalene synthetic enzyme
10/16/1996CN1133190A Shengfabao tablet for promoting hair growth
10/16/1996CN1133171A Skin health care cream for beauty
10/15/1996US5565560 Treating autoimmune diseases, preventing transplant rejection
10/15/1996US5565462 Pentoxifylline, propentofylline and(or) torbafylline
10/15/1996US5565435 Enzyme catalyzed reaction between quercetin and glucose
10/10/1996WO1996031514A1 Ascomycins
10/10/1996WO1996031492A1 Thienyl-, furyl-, pyrrolyl- and biphenylsulfonamides and derivatives thereof that modulate the activity of endothelin
10/10/1996WO1996031487A1 1,3-dihydro-2h-imidazol-2-one derivatives having pde iv and cytokinin inhibiting activity
10/10/1996WO1996031486A1 1,3-dihydro-1-(phenylalkenyl)-2h-imidazol-2-one derivatives having pde iv and cytokine inhibiting activity
10/10/1996WO1996031485A1 1,3-dihydro-1-(phenylalkyl)-2h-imidazol-2-one derivatives having pdeiv and cytokine activity
10/10/1996WO1996031452A1 9-substituted porphycenes
10/10/1996WO1996031451A1 9-substituted porphycenes
10/10/1996WO1996020215A3 Use of mhc-ii binding and/or mhc-ii mimicking molecules for the prevention and/or treatment of inflammatory diseases
10/10/1996CA2217213A1 9-substituted porphycenes
10/10/1996CA2216562A1 Ascomycins
10/10/1996CA2214411A1 9-substituted porphycenes
10/09/1996EP0736530A2 Retinoid-like heterocycles
10/09/1996EP0736527A1 Imadazoline derivative, possible tautomer thereof, process of manufacturing therefor, and vulnerary including such derivative or tautomer
10/09/1996EP0736522A1 Ceramide compounds, process for their preparation and their use in cosmetics or dermatology
10/09/1996EP0736032A1 Heterocyclic compounds
10/09/1996EP0736006A1 Phenylthiophenyl cycloalkenyl hydroxyureas as lipoxygenase inhibitors
10/09/1996EP0735885A1 Psoriasis treatment
10/09/1996EP0735881A1 Means and method for hormonal contraception and/or the treatment of acne
10/09/1996EP0735872A1 A method of treating neurogenic inflammation
10/09/1996EP0735818A1 MACROPHAGE INFLAMMATORY PROTEINS-3, -4 AND -1 Sg(g)
10/09/1996CN1132755A Aescinic lactonic derivative, its prep. and medicine composition thereof
10/09/1996CN1132637A Liniment and its prepn
10/09/1996CN1132607A Fortified fruit juices
10/08/1996US5563255 Antisense oligonucleotide modulation of raf gene expression
10/08/1996US5563165 Prostaglandin inhibitor; fda orange book listed patent for celebrex
10/08/1996US5563143 Antiinflammatory agents, autoimmune disorders
10/06/1996CA2173047A1 Retinoid-like heterocycles
10/03/1996WO1996030347A1 Quinazoline derivatives
10/03/1996WO1996030048A1 Protein kinase c inhibitors
10/03/1996WO1996030009A2 Compositions for treatment of photodamaged skin comprising an rar-alpha antagonist and a multi-selective retinoid
10/03/1996WO1996029974A2 Compositions and methods utilizing nitroxides in combination with biocompatible macromolecules
10/03/1996WO1996023489A3 Use of carotinoids for preparing medicaments for treating dermatoses
10/03/1996CA2216651A1 Compositions and methods utilizing nitroxides in combination with biocompatible macromolecules
10/02/1996EP0735038A1 Protein kinase C inhibitors
10/02/1996EP0734730A1 Use of a CGRP antagonist for the treatment of ocular or eyelid pruritis and disesthesies
10/02/1996EP0734729A1 Use of a CGRP antagonist for the treatment of cutaneous erythema of neurogenic origin and so obtained composition
10/02/1996EP0734728A1 Use of a CGRP antagonist for the treatment of lichens and pruritis and composition so obtained
10/02/1996EP0734394A1 Peptide inhibitors of cxc intercrine molecules
10/02/1996EP0734386A1 Platelet activating factor antagonists: imidazopyridine indoles
10/02/1996EP0734376A1 Vitamin d amine and amide derivatives
10/02/1996EP0734371A1 Novel retinoid conjugate compounds and methods for treating skin aging
10/02/1996EP0663812B1 Use of alkylpolyglycosides and/or o-acylated derivatives of glucose for treating hair loss
10/02/1996CN1132479A Mycophenolate mofetil high dose oral suspensions
10/02/1996CN1132084A Chinese medicine for curing haemorrhoids inflammation and its prepn. process
10/02/1996CN1132080A Medicine for treatment of burn and sore and its prepn. method
10/02/1996CN1132078A Burn medicine and prepn. method thereof
10/02/1996CN1032900C Method for prep. of locally-used metrohidazole formulations
10/01/1996US5561228 Immunosuppressnats; side effect reduction
10/01/1996US5561123 Antitumor agents, anticarcinogenic agent
10/01/1996US5560916 Cosmetic composition containing vinegar as active anti-ageing agent, and its use in the treatment of dermatological ageing
10/01/1996US5560904 Cosmetic and/or dermatological composition containing a glyceryl tri(.alpha.
09/1996
09/26/1996WO1996029315A2 Imidazole derivatives as histamine receptor h3 (ant)agonists
09/26/1996WO1996029313A1 Lactam-containing hydroxamic acid derivatives, their preparation and their use as inhibitors of matrix metalloprotease
09/26/1996WO1996029080A1 Poly(hydroxy acid)/polymer conjugates for skin applications
09/26/1996WO1996029056A1 Topically applied pharmaceutical composition, method of preparing it and its use
09/26/1996WO1996029050A1 Depigmenting dermatological and/or cosmetic composition
09/26/1996WO1996028975A1 Topical antimicrobial agents
09/26/1996WO1996023065A3 Inhibition of neovascularization using vegf-specific oligonucleotides
09/26/1996WO1996022760A3 Antagonists of alpha-melanocyte stimulating hormone and methods based thereon
09/26/1996DE4396528C1 Abalone shell powder and sesame oil compsn for burn treatment
09/26/1996CA2190865A1 Imidazole derivatives as histamine receptor h3 (ant)agonists
09/25/1996EP0733702A1 Stable transglutaminase preparations and process for their preparation
09/25/1996EP0733107A1 C5a RECEPTOR ANTAGONISTS HAVING SUBSTANTIALLY NO AGONIST ACTIVITY
09/25/1996EP0733071A1 Antagonists to chaperonin 10
09/25/1996EP0733047A1 Novel substituted oxazolidines
09/25/1996EP0733044A1 Compounds
09/25/1996EP0732940A1 Inhibition of extracellular matrix synthesis by antisense compounds directed to nuclear proto-oncogenes
09/25/1996EP0732930A1 Compositions which inhibit apoptosis, methods of purifying the compositions and uses thereof
09/25/1996EP0732929A1 Therapeutic use of cis-element decoys in vivo
09/25/1996EP0732928A1 Method of lowering serum cholesterol levels with 2,6-di-alkyl-4-silyl-phenols
09/24/1996US5559248 For prevention and treatment of skin disorders
09/24/1996US5559123 Derivatives of benzoylecgonine, ecgonine and ecgonidine and methods for preparing and using same
09/24/1996US5558871 Vegetable oil
09/24/1996CA2087145C Composition for accelerating wound healing
09/19/1996WO1996028547A1 Dermatomyositis-specific auto-antigen
09/19/1996WO1996028543A1 New defined enzyme mixtures for obtaining cells and treating wounds
09/19/1996WO1996028476A1 Process for glucan preparation and therapeutic uses of glucan
09/19/1996WO1996028430A1 Trisubstituted phenyl derivatives
09/19/1996WO1996028186A1 Use of g class immunoglobulins for the topical treatment of atopic dermatitis